Cooper Companies | Lånekapital



Loan Capital Endring Dato
Abbott USD 12.74B 111M 2025-03
Align Technology USD 0 0 2024-12
AtriCure USD 61.86M 7.28M 2025-03
Avanos Medical USD 125.3M 27.3M 2024-12
Bausch Health Companies USD 21.23B 2.29B 2025-03
Baxter International USD 10.37B 63M 2024-12
Bayer EUR 34.55B 2.12B 2024-12
Becton, Dickinson and Co. USD 17.44B 500M 2024-12
Boston Scientific USD 8.97B 265M 2024-12
Cooper Companies USD 2.49B 59.2M 2025-01
Dentsply International USD 1.59B 209M 2024-12
Dexcom USD 1.3B 1.2B 2024-12
Edwards Lifesciences USD 597.7M 200K 2024-12
Globus Medical USD 298K 411K 2024-12
Haemonetics USD 1.22B 239K 2024-12
Hologic USD 2.49B 19M 2024-12
Insulet USD 1.3B 60.2M 2024-12
Integra LifeSciences USD 1.2B 9.07M 2024-12
Intuitive Surgical USD 0 0 2025-03
J&J USD 38.36B 7.7B 2025-03
Medtronic USD 23.99B 622M 2025-01
Merit Medical Systems USD 730.67M 1.12M 2025-03
Novartis USD 22.93B 2.41B 2024-12
ResMed USD 663.13M 267K 2025-03
STAAR Surgical USD 0 0 2024-12
Steris USD 2.04B 117.43M 2024-12
Stryker USD 12.19B 1.14B 2024-12
Tandem Diabetes Care USD 313.6M 5.34M 2025-03
Teleflex USD 1.81B 251.45M 2025-03
Zimmer Biomet Holdings USD 5.34B 603.9M 2024-12



Cooper Companies Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.